Buscar resultados de ensayos clínicos
Hypophosphatemia - 68 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients Condición:
|
Recruiting |
Nombre del estudio: Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project. Condición: Autosomal Dominant Hypophosphatemic Rickets Fecha: 2014-08-27 Intervenciones: Dietary Supplement: Iron All subjects will receive iron supplementation based on iron levels in the bloo |
Completed |
Nombre del estudio: Growth Hormone Treatment in Children With Hypophosphatemic Rickets Condición: X Linked Hypophosphatemic Rickets Fecha: 2016-03-15 Intervenciones: Drug: norditropine simplex Other Name: growth hormone |
Completed |
Nombre del estudio: A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia Condición: X-linked Hypophosphatemic Rickets/Osteomalacia Fecha: 2014-07-02 Intervenciones: Drug: KRN23 Single SC administration on day 1: 0.3, 0.6 and 1.0 mg/kg |
Completed |
Nombre del estudio: Assessment Of Vitamin D Role In The Pathogenesis Of Asthma In Vitamin D Resistent Patients Condición:
Fecha: 2011-11-09 Intervenciones: Other: Methacholine Challenge Test Evaluation of airway hyperreactivity as assessed by doubling dose of |
Completed |
Nombre del estudio: Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets Condición:
Fecha: 2006-12-28 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Hypophosphatemic Rickets in Norway Condición:
|
Completed |
Nombre del estudio: Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4 Condición: Chronic Kidney Disease Fecha: 2008-10-01 Intervenciones:
|
Recruiting |
Nombre del estudio: Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH) Condición: X-Linked Hypophosphatemia Fecha: 2016-05-23 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH) Condición: X-Linked Hypophosphatemia Fecha: 2015-12-06 Intervenciones: Drug: KRN23 |